This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n7http://linked.opendata.cz/resource/drugbank/drug/DB09002/identifier/wikipedia/
dctermshttp://purl.org/dc/terms/
foafhttp://xmlns.com/foaf/0.1/
n13http://linked.opendata.cz/resource/drugbank/drug/DB09002/identifier/kegg-drug/
n12http://linked.opendata.cz/resource/drugbank/drug/DB09002/identifier/drugbank/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://www.drugs.com/international/
n9http://linked.opendata.cz/resource/atc/
n8http://linked.opendata.cz/ontology/sukl/drug/

Statements

Subject Item
n2:DB09002
rdf:type
n3:Drug
n3:description
Cloperastine is a cough suppressant that acts on the central nervous system.
n3:generalReferences
# Serrano M, Sanz-Cuesta M, Villaronga M, Hayek LF, Perez-Duenas B: Cloperastine-based cough syrup and acute dystonic reactions. Dev Med Child Neurol. 2012 Mar;54(3):287. doi: 10.1111/j.1469-8749.2011.04105.x. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/22324643
n3:group
approved investigational
owl:sameAs
n11:DB09002
dcterms:title
Cloperastine
adms:identifier
n7:Cloperastine n12:DB09002 n13:D03557
n3:salt
n3:synthesisReference
Merck Index 2358.
foaf:page
n15:cloperastine.html
n3:IUPAC-Name
n4:271B63E3-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B63E9-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B63E8-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B63E5-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B63E6-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B63E7-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B63E1-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B63DF-363D-11E5-9242-09173F13E4C5 n4:271B63E2-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B63E0-363D-11E5-9242-09173F13E4C5
n8:hasATCCode
n9:R05DB21
n3:H-Bond-Acceptor-Count
n4:271B63EF-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B63F0-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B63EA-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B63EB-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B63ED-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B63EC-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B63EE-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
3703-76-2
n3:Bioavailability
n4:271B63F4-363D-11E5-9242-09173F13E4C5
n3:Boiling-Point
n4:271B63F8-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B63F6-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B63F7-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B63F3-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B63F2-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B63F5-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B63E4-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B63F1-363D-11E5-9242-09173F13E4C5